Work

JAK2 L884P Mutation Confers Resistance To The Type II JAK2 Inhibitor NVP-BBT594 When Co-Occurring With JAK2 R683G But Not JAK2 V617F

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.1429.1429

Authors: Nadja Kopp, Jordy C. Van der Zwet, Jacob Layer, Oliver Weigert, Eric Vangrevelinghe, Akinori Yoda, Thomas Radimerski, David Weinstock

Institutions: Dana-Farber Cancer Institute, LMU Klinikum, Ludwig-Maximilians-Universität München, Novartis (Switzerland), Novartis Institutes for BioMedical Research

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2412706360

FWCI:

Cites:

Cited by:

Related to: 10